NYSTATIN AND TRIAMCINOLONE ACETONIDE

NYSTATIN AND TRIAMCINOLONE ACETONIDE was reported 105 times

NYSTATIN AND TRIAMCINOLONE ACETONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDIASTINAL INFECTION 1 0.5000
1 VITAMIN C ABNORMAL 1 0.1111
2 CONTRACEPTION 1 0.0370
3 BRONCHIAL HYPERACTIVITY 1 0.0227
4 NUCLEATED RED CELLS 1 0.0089
5 GENITAL INJURY 1 0.0075
6 CSF CELL COUNT INCREASED 1 0.0068
7 ENTEROBACTER PNEUMONIA 1 0.0064
8 UROBILINOGEN URINE INCREASED 1 0.0061
9 BORDERLINE GLAUCOMA 1 0.0054
10 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
11 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
12 POLYCHROMASIA 1 0.0033
13 TRANSFERRIN SATURATION INCREASED 1 0.0029
14 URINARY CASTS 1 0.0026
15 VASCULAR INSUFFICIENCY 1 0.0026
16 STICKY SKIN 1 0.0025
17 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
18 NITRITE URINE PRESENT 1 0.0023
19 POST THROMBOTIC SYNDROME 1 0.0022
20 TINEA CRURIS 1 0.0020
21 CSF TEST ABNORMAL 1 0.0020
22 POSTURING 1 0.0019
23 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
24 PRODUCT CLOSURE ISSUE 1 0.0018
25 PERFUME SENSITIVITY 1 0.0018
26 OPEN ANGLE GLAUCOMA 1 0.0016
27 URINARY SEDIMENT PRESENT 1 0.0016
28 VULVAL DISORDER 1 0.0015
29 PAINFUL ERECTION 1 0.0015
30 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
31 MONOCYTE PERCENTAGE INCREASED 1 0.0014
32 PRODUCT DESIGN ISSUE 1 0.0014
33 HAPTOGLOBIN DECREASED 1 0.0012
34 RETICULOCYTE COUNT INCREASED 1 0.0012
35 MEAN PLATELET VOLUME DECREASED 1 0.0012
36 RED BLOOD CELLS URINE POSITIVE 1 0.0010
37 ANTISOCIAL BEHAVIOUR 1 0.0010
38 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
39 STEROID WITHDRAWAL SYNDROME 1 0.0010
40 PRODUCT SELECTION ERROR 1 0.0009
41 CARBON DIOXIDE DECREASED 1 0.0009
42 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
43 MONOCYTE COUNT DECREASED 1 0.0008
44 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
45 OVARIAN CYST RUPTURED 1 0.0008
46 LIP EXFOLIATION 1 0.0008
47 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
48 VULVOVAGINAL CANDIDIASIS 1 0.0007
49 CULTURE URINE POSITIVE 1 0.0007
50 BACTERIAL VAGINOSIS 1 0.0006
51 BLOOD CHLORIDE INCREASED 1 0.0006
52 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
53 PNEUMONIA KLEBSIELLA 1 0.0005
54 BLOOD IRON INCREASED 1 0.0005
55 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
56 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
57 NEUROGENIC BLADDER 1 0.0005
58 MIDDLE EAR EFFUSION 1 0.0005
59 BACTERIAL TEST POSITIVE 1 0.0004
60 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
61 RADICULOPATHY 1 0.0004
62 APPLICATION SITE HAEMORRHAGE 1 0.0004
63 APPLICATION SITE PAIN 8 0.0004
64 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
65 PRODUCT CONTAINER ISSUE 3 0.0003
66 PARAPLEGIA 1 0.0003
67 HAEMOTHORAX 1 0.0003
68 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
69 URINE ANALYSIS ABNORMAL 1 0.0003
70 PENILE PAIN 1 0.0003
71 BLOOD CREATININE DECREASED 1 0.0003
72 PLANTAR FASCIITIS 1 0.0003
73 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
74 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
75 PRODUCT STORAGE ISSUE 1 0.0003
76 CERVIX CARCINOMA 1 0.0003
77 APPLICATION SITE DISCOLOURATION 1 0.0002
78 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
79 UTERINE HAEMORRHAGE 1 0.0002
80 ONYCHOMYCOSIS 1 0.0002
81 RHINITIS ALLERGIC 1 0.0002
82 VAGINAL INFECTION 1 0.0002
83 SKIN ABRASION 1 0.0002
84 VULVOVAGINAL PAIN 1 0.0002
85 PROTEIN URINE PRESENT 1 0.0002
86 VULVOVAGINAL PRURITUS 1 0.0002
87 BLOOD LACTIC ACID INCREASED 1 0.0002
88 SERUM FERRITIN INCREASED 1 0.0002
89 ANORECTAL DISCOMFORT 1 0.0002
90 CHEILITIS 1 0.0002
91 APPLICATION SITE PRURITUS 4 0.0002
92 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
93 PROTHROMBIN TIME PROLONGED 1 0.0002
94 APPLICATION SITE IRRITATION 2 0.0002
95 HAEMOGLOBIN ABNORMAL 1 0.0002
96 APPLICATION SITE VESICLES 1 0.0002
97 WRONG PRODUCT ADMINISTERED 1 0.0001
98 PRODUCT LABEL ISSUE 1 0.0001
99 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
100 BREAST TENDERNESS 1 0.0001
101 HAEMOLYSIS 1 0.0001
102 BLOOD ALBUMIN DECREASED 1 0.0001
103 DECUBITUS ULCER 1 0.0001
104 PYELONEPHRITIS 1 0.0001
105 APPLICATION SITE ERYTHEMA 3 0.0001
106 GROIN PAIN 1 0.0001
107 WRONG DRUG ADMINISTERED 1 0.0001
108 LOSS OF LIBIDO 1 0.0001
109 LIP DRY 1 0.0001
110 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
111 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
112 AFFECT LABILITY 1 0.0001
113 VITAMIN D DEFICIENCY 1 0.0001
114 KIDNEY INFECTION 2 0.0001
115 OVARIAN CYST 1 0.0001
116 VAGINAL DISCHARGE 1 0.0001
117 NEUTROPHIL COUNT INCREASED 1 0.0001
118 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
119 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
120 SKIN LACERATION 1 0.0001
121 PRODUCT DISPENSING ERROR 2 0.0001
122 GASTROINTESTINAL PAIN 1 0.0001
123 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
124 EXPIRED PRODUCT ADMINISTERED 3 0.0001
125 MITRAL VALVE INCOMPETENCE 1 0.0001
126 MYOCARDIAL ISCHAEMIA 1 0.0001
127 MUSCLE SPASTICITY 1 0.0001
128 DERMATITIS ALLERGIC 1 0.0001
129 ROTATOR CUFF SYNDROME 1 0.0001
130 PLATELET COUNT INCREASED 1 0.0001
131 INCORRECT PRODUCT STORAGE 1 0.0001
132 APPLICATION SITE RASH 1 0.0001
133 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
134 CARDIOMYOPATHY 1 0.0001
135 IMMUNODEFICIENCY 1 0.0001
136 OSTEOPENIA 1 0.0001
137 LYMPHOMA 1 0.0001
138 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
139 BLOOD POTASSIUM INCREASED 1 0.0001
140 FUNGAL INFECTION 2 0.0001
141 BLOOD UREA INCREASED 1 0.0001
142 BURNING SENSATION 4 0.0001
143 LYMPHOCYTE COUNT DECREASED 1 0.0001
144 HEAD DISCOMFORT 1 0.0001
145 TOOTHACHE 1 0.0001
146 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
147 BLOOD URINE PRESENT 1 0.0001
148 DRUG PRESCRIBING ERROR 1 0.0001
149 SKIN FISSURES 1 0.0001
150 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
151 HAEMATOCRIT DECREASED 1 0.0001
152 BLOOD PRESSURE ABNORMAL 1 0.0001
153 PRODUCT ADMINISTRATION ERROR 1 0.0000
154 DERMATITIS 1 0.0000
155 SKIN CANCER 1 0.0000
156 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
157 PRODUCT PRESCRIBING ISSUE 1 0.0000
158 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
159 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
160 CHROMATURIA 1 0.0000
161 SKIN IRRITATION 2 0.0000
162 BLOOD CHOLESTEROL INCREASED 2 0.0000
163 RASH ERYTHEMATOUS 2 0.0000
164 NEURALGIA 1 0.0000
165 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
166 MENSTRUATION IRREGULAR 1 0.0000
167 DRUG EFFECT DECREASED 2 0.0000
168 FREQUENT BOWEL MOVEMENTS 1 0.0000
169 BLOOD BILIRUBIN INCREASED 1 0.0000
170 LIMB INJURY 1 0.0000
171 WOUND 1 0.0000
172 PAIN IN JAW 1 0.0000
173 RED BLOOD CELL COUNT DECREASED 1 0.0000
174 EYE IRRITATION 2 0.0000
175 ACUTE MYOCARDIAL INFARCTION 1 0.0000
176 URINARY INCONTINENCE 1 0.0000
177 BLOOD POTASSIUM DECREASED 1 0.0000
178 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
179 CORONARY ARTERY DISEASE 1 0.0000
180 CYSTITIS 1 0.0000
181 SWELLING FACE 2 0.0000
182 SKIN DISORDER 1 0.0000
183 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
184 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
185 DELIRIUM 1 0.0000
186 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
187 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
188 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
189 C-REACTIVE PROTEIN INCREASED 1 0.0000
190 DYSGEUSIA 2 0.0000
191 DYSARTHRIA 1 0.0000
192 JOINT SWELLING 3 0.0000
193 OSTEOPOROSIS 1 0.0000
194 CARDIO-RESPIRATORY ARREST 1 0.0000
195 SKIN EXFOLIATION 2 0.0000
196 URINARY TRACT INFECTION 4 0.0000
197 HYPOACUSIS 1 0.0000
198 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
199 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
200 PRODUCT QUALITY ISSUE 3 0.0000
201 NEPHROLITHIASIS 1 0.0000
202 HYPOKALAEMIA 1 0.0000
203 COGNITIVE DISORDER 1 0.0000
204 DISEASE RECURRENCE 1 0.0000
205 BLOOD GLUCOSE DECREASED 1 0.0000
206 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
207 PRURITUS 8 0.0000
208 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
209 INFLAMMATION 1 0.0000
210 ECZEMA 1 0.0000
211 DERMATITIS ATOPIC 1 0.0000
212 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
213 ANAPHYLACTIC REACTION 1 0.0000
214 MEDICATION ERROR 1 0.0000
215 HYPONATRAEMIA 1 0.0000
216 EYE PAIN 1 0.0000
217 FLATULENCE 1 0.0000
218 DRUG INEFFECTIVE 23 0.0000
219 PRODUCT SUBSTITUTION ISSUE 1 0.0000
220 DYSPHONIA 1 0.0000
221 PLEURAL EFFUSION 1 0.0000
222 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
223 PRODUCT DOSE OMISSION 1 0.0000
224 DRY SKIN 2 0.0000
225 WEIGHT DECREASED 4 0.0000
226 THERAPY INTERRUPTED 1 0.0000
227 AGITATION 1 0.0000
228 PERIPHERAL SWELLING 2 0.0000
229 CARDIAC FAILURE CONGESTIVE 1 0.0000
230 ABDOMINAL DISCOMFORT 2 0.0000
231 RASH 5 0.0000
232 INSOMNIA 3 0.0000
233 NO ADVERSE EVENT 2 0.0000
234 MUSCLE SPASMS 2 0.0000
235 OROPHARYNGEAL PAIN 1 0.0000
236 CHEST PAIN 2 0.0000
237 BLOOD GLUCOSE INCREASED 2 0.0000
238 DYSPHAGIA 1 0.0000
239 MIGRAINE 1 0.0000
240 ATRIAL FIBRILLATION 1 0.0000
241 SYNCOPE 1 0.0000
242 CONDITION AGGRAVATED 3 0.0000
243 SINUSITIS 1 0.0000
244 ERYTHEMA 2 0.0000
245 ILLNESS 1 0.0000
246 HAEMORRHAGE 1 0.0000
247 INFLUENZA 1 0.0000
248 DEPRESSION 2 0.0000
249 CHILLS 1 0.0000
250 OEDEMA PERIPHERAL 1 0.0000
251 PAIN 5 0.0000
252 RENAL FAILURE 1 0.0000
253 VISION BLURRED 1 0.0000
254 INFECTION 1 0.0000
255 HYPOAESTHESIA 1 0.0000
256 BLOOD PRESSURE INCREASED 1 0.0000
257 VOMITING 3 0.0000
258 DRUG INTERACTION 1 0.0000
259 DIARRHOEA 4 0.0000
260 CONFUSIONAL STATE 1 0.0000
261 TREMOR 1 0.0000
262 CEREBROVASCULAR ACCIDENT 1 0.0000
263 OFF LABEL USE 5 0.0000
264 COVID-19 1 0.0000
265 ANAEMIA 1 0.0000
266 GAIT DISTURBANCE 1 0.0000
267 FATIGUE 4 0.0000
268 NAUSEA 4 0.0000
269 HEADACHE 3 0.0000
270 CONSTIPATION 1 0.0000
271 MALAISE 2 0.0000
272 WEIGHT INCREASED 1 0.0000
273 INCORRECT DOSE ADMINISTERED 1 0.0000
274 BACK PAIN 1 0.0000
275 ABDOMINAL PAIN 1 0.0000
276 FEELING ABNORMAL 1 0.0000
277 DIZZINESS 2 0.0000
278 PNEUMONIA 1 0.0000
279 PYREXIA 1 0.0000
280 ASTHENIA 1 0.0000
281 DYSPNOEA 1 0.0000